FILE:WAG/WAG-8K-20100324162520.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 This amendment to the current report on Form 8-K filed by Walgreen Co. on March 1, 2010 (the Original Report) is being filed to disclose the following information, which was not determined when the Original Report was filed: (1) the effective date of Stanley B. Blaylocks separation from the Company; and (2) the material terms and conditions of Mr. Blaylocks Separation and Release Agreement
   
.
 
 
 On February 23, 2010, Stanley B. Blaylock, senior vice president of Walgreen Co. (the Company) and president of Walgreens Health Services, informed the Company that he will leave the Company in April after a transition period.  Subsequently, the parties agreed on April 2, 2010 as the effective date of Mr. Blaylocks separation from the Company (Separation Date).
   
 
 Mr. Blaylock and the Company have entered into a Separation and Release Agreement to confirm the terms and conditions of Mr. Blaylocks separation from the Company.  The material terms and conditions of the Agreement are as follows:
   
SIGNATURE
 
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
   
 


